Peter Baker
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Addison Disease | 5 | 2014 | 38 | 1.530 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 3 | 2021 | 24 | 1.420 |
Why?
| | Steroid 21-Hydroxylase | 4 | 2014 | 27 | 1.220 |
Why?
| | Energy Metabolism | 5 | 2026 | 936 | 1.010 |
Why?
| | Metabolism, Inborn Errors | 3 | 2021 | 42 | 0.960 |
Why?
| | Amino Acids | 6 | 2026 | 522 | 0.930 |
Why?
| | Metabolomics | 5 | 2026 | 727 | 0.840 |
Why?
| | Glutathione | 2 | 2026 | 375 | 0.780 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.770 |
Why?
| | Adiposity | 2 | 2017 | 543 | 0.750 |
Why?
| | Acute Kidney Injury | 3 | 2026 | 866 | 0.750 |
Why?
| | Autoantibodies | 6 | 2015 | 1504 | 0.740 |
Why?
| | Nutritional Status | 3 | 2023 | 354 | 0.710 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2026 | 49 | 0.670 |
Why?
| | Vitamin B 12 | 1 | 2021 | 127 | 0.660 |
Why?
| | Methionine | 1 | 2021 | 162 | 0.660 |
Why?
| | Fatty Acids | 3 | 2026 | 452 | 0.650 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.640 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2023 | 219 | 0.640 |
Why?
| | Isoleucine | 1 | 2020 | 15 | 0.630 |
Why?
| | Fetal Macrosomia | 1 | 2020 | 62 | 0.610 |
Why?
| | Valine | 1 | 2020 | 80 | 0.610 |
Why?
| | Obesity | 7 | 2018 | 3082 | 0.600 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.570 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2018 | 266 | 0.560 |
Why?
| | Epilepsy | 1 | 2023 | 387 | 0.560 |
Why?
| | Dietary Supplements | 2 | 2020 | 576 | 0.560 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 113 | 0.560 |
Why?
| | Mitochondria, Liver | 1 | 2018 | 70 | 0.550 |
Why?
| | Neonatal Screening | 1 | 2020 | 178 | 0.550 |
Why?
| | Neuroimaging | 1 | 2020 | 292 | 0.530 |
Why?
| | Kidney | 2 | 2026 | 1496 | 0.510 |
Why?
| | Muscle, Skeletal | 5 | 2026 | 1796 | 0.500 |
Why?
| | Liver | 2 | 2024 | 1888 | 0.470 |
Why?
| | Poland Syndrome | 1 | 2014 | 2 | 0.440 |
Why?
| | Mice, Inbred C57BL | 3 | 2026 | 5997 | 0.440 |
Why?
| | Oxidative Stress | 5 | 2024 | 1339 | 0.430 |
Why?
| | HLA-A2 Antigen | 1 | 2014 | 35 | 0.430 |
Why?
| | Birth Weight | 1 | 2017 | 522 | 0.420 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2014 | 77 | 0.420 |
Why?
| | HLA-B Antigens | 2 | 2011 | 57 | 0.420 |
Why?
| | Sequence Deletion | 1 | 2014 | 193 | 0.420 |
Why?
| | Acidosis, Lactic | 2 | 2024 | 45 | 0.420 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.410 |
Why?
| | Homocystinuria | 1 | 2014 | 62 | 0.410 |
Why?
| | HLA-DR3 Antigen | 2 | 2012 | 76 | 0.410 |
Why?
| | Glutaredoxins | 1 | 2013 | 15 | 0.410 |
Why?
| | Metabolome | 3 | 2026 | 384 | 0.390 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2013 | 56 | 0.390 |
Why?
| | Carnitine | 3 | 2020 | 90 | 0.380 |
Why?
| | Genetic Variation | 2 | 2019 | 984 | 0.380 |
Why?
| | Gene Expression | 1 | 2017 | 1490 | 0.380 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 906 | 0.370 |
Why?
| | Genetic Predisposition to Disease | 7 | 2015 | 2365 | 0.370 |
Why?
| | Ischemia | 2 | 2026 | 421 | 0.350 |
Why?
| | Ring Chromosomes | 1 | 2010 | 3 | 0.330 |
Why?
| | Endocrine Cells | 1 | 2010 | 6 | 0.330 |
Why?
| | Carrier Proteins | 1 | 2014 | 737 | 0.320 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 76 | 0.320 |
Why?
| | Abnormalities, Multiple | 2 | 2018 | 197 | 0.320 |
Why?
| | Mosaicism | 1 | 2010 | 73 | 0.310 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2015 | 3890 | 0.310 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2738 | 0.300 |
Why?
| | Haplotypes | 4 | 2012 | 490 | 0.300 |
Why?
| | Biomarkers | 6 | 2026 | 4275 | 0.300 |
Why?
| | Humans | 35 | 2026 | 144957 | 0.300 |
Why?
| | Lipid Metabolism | 3 | 2018 | 528 | 0.300 |
Why?
| | Male | 21 | 2026 | 72406 | 0.290 |
Why?
| | Face | 1 | 2010 | 174 | 0.290 |
Why?
| | Infant | 10 | 2024 | 10039 | 0.290 |
Why?
| | Autoimmunity | 2 | 2015 | 927 | 0.280 |
Why?
| | Fetus | 4 | 2021 | 803 | 0.280 |
Why?
| | Mutation | 3 | 2026 | 4099 | 0.270 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2018 | 181 | 0.270 |
Why?
| | Proteins | 1 | 2013 | 1022 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3869 | 0.260 |
Why?
| | Pregnancy | 9 | 2021 | 7191 | 0.260 |
Why?
| | Infant, Newborn | 5 | 2024 | 6434 | 0.260 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2026 | 20 | 0.240 |
Why?
| | Azotemia | 1 | 2026 | 13 | 0.240 |
Why?
| | Female | 21 | 2021 | 78376 | 0.230 |
Why?
| | Glycosylation | 2 | 2023 | 172 | 0.220 |
Why?
| | Databases, Genetic | 1 | 2026 | 249 | 0.220 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 7 | 0.220 |
Why?
| | Genotype | 6 | 2026 | 1835 | 0.210 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2024 | 47 | 0.210 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.210 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.210 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.210 |
Why?
| | Cardiomyopathies | 2 | 2026 | 338 | 0.210 |
Why?
| | Transcription Factors, General | 1 | 2023 | 5 | 0.200 |
Why?
| | Niacinamide | 1 | 2024 | 86 | 0.200 |
Why?
| | Sheep | 3 | 2021 | 880 | 0.200 |
Why?
| | Keto Acids | 1 | 2023 | 13 | 0.200 |
Why?
| | HLA-DRB1 Chains | 2 | 2015 | 109 | 0.200 |
Why?
| | Mitochondria | 2 | 2021 | 984 | 0.190 |
Why?
| | Molecular Chaperones | 1 | 2024 | 200 | 0.190 |
Why?
| | Siblings | 1 | 2023 | 195 | 0.190 |
Why?
| | Glycolysis | 1 | 2024 | 340 | 0.180 |
Why?
| | HLA-B15 Antigen | 2 | 2012 | 12 | 0.180 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.180 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 57 | 0.180 |
Why?
| | Intellectual Disability | 1 | 2023 | 175 | 0.180 |
Why?
| | Placental Insufficiency | 2 | 2021 | 125 | 0.180 |
Why?
| | HLA-B8 Antigen | 2 | 2012 | 11 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 477 | 0.170 |
Why?
| | Lactic Acid | 1 | 2023 | 302 | 0.170 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 675 | 0.170 |
Why?
| | Mutation, Missense | 1 | 2023 | 340 | 0.170 |
Why?
| | Pregnancy Complications | 2 | 2018 | 592 | 0.170 |
Why?
| | Metabolism | 1 | 2021 | 44 | 0.170 |
Why?
| | Homocysteine | 1 | 2021 | 151 | 0.170 |
Why?
| | Phenotype | 4 | 2026 | 3164 | 0.170 |
Why?
| | Adult | 10 | 2021 | 40506 | 0.160 |
Why?
| | Oxidation-Reduction | 3 | 2026 | 1087 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2021 | 249 | 0.160 |
Why?
| | Propionic Acidemia | 1 | 2020 | 3 | 0.160 |
Why?
| | Neurodevelopmental Disorders | 1 | 2023 | 227 | 0.160 |
Why?
| | Leucine | 1 | 2020 | 116 | 0.160 |
Why?
| | Proteomics | 3 | 2024 | 1195 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4569 | 0.150 |
Why?
| | False Positive Reactions | 1 | 2020 | 122 | 0.150 |
Why?
| | Albinism | 1 | 2019 | 3 | 0.150 |
Why?
| | Lysosomal Storage Diseases | 1 | 2019 | 5 | 0.150 |
Why?
| | Acids | 1 | 2019 | 17 | 0.150 |
Why?
| | Animals | 10 | 2026 | 38109 | 0.150 |
Why?
| | Chloride Channels | 1 | 2019 | 34 | 0.150 |
Why?
| | Disease Progression | 2 | 2020 | 2852 | 0.140 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.140 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 587 | 0.140 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2018 | 39 | 0.140 |
Why?
| | Dystroglycans | 1 | 2018 | 6 | 0.140 |
Why?
| | Colorado | 2 | 2020 | 4564 | 0.140 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 7 | 0.140 |
Why?
| | Glucose | 2 | 2021 | 1049 | 0.140 |
Why?
| | Leptin | 2 | 2018 | 245 | 0.140 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 30 | 0.140 |
Why?
| | Preconception Care | 1 | 2018 | 50 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 412 | 0.140 |
Why?
| | Micronutrients | 1 | 2018 | 96 | 0.130 |
Why?
| | Insulin | 3 | 2018 | 2507 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2020 | 216 | 0.130 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.130 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 86 | 0.130 |
Why?
| | Electron Transport | 1 | 2017 | 118 | 0.130 |
Why?
| | Maternal-Fetal Exchange | 1 | 2018 | 169 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2024 | 2499 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2023 | 1167 | 0.130 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 93 | 0.120 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 7 | 0.120 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 19 | 0.120 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 463 | 0.120 |
Why?
| | Disease Susceptibility | 1 | 2018 | 348 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 577 | 0.120 |
Why?
| | Mice | 5 | 2026 | 18365 | 0.120 |
Why?
| | Lipids | 2 | 2021 | 710 | 0.120 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2015 | 15 | 0.120 |
Why?
| | Hyperlipidemias | 1 | 2016 | 122 | 0.110 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 81 | 0.110 |
Why?
| | Adipogenesis | 1 | 2015 | 57 | 0.110 |
Why?
| | Retinal Diseases | 1 | 2016 | 101 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2147 | 0.110 |
Why?
| | Fetal Development | 1 | 2018 | 299 | 0.110 |
Why?
| | Lower Extremity | 1 | 2019 | 438 | 0.110 |
Why?
| | HLA-DP beta-Chains | 1 | 2015 | 87 | 0.110 |
Why?
| | Pediatric Obesity | 2 | 2020 | 638 | 0.110 |
Why?
| | Body Mass Index | 3 | 2018 | 2438 | 0.110 |
Why?
| | Alleles | 3 | 2015 | 881 | 0.110 |
Why?
| | PPAR gamma | 1 | 2015 | 177 | 0.110 |
Why?
| | Postprandial Period | 1 | 2015 | 118 | 0.110 |
Why?
| | Oxidoreductases | 1 | 2014 | 96 | 0.100 |
Why?
| | Milk, Human | 1 | 2016 | 172 | 0.100 |
Why?
| | Genetic Association Studies | 3 | 2026 | 373 | 0.100 |
Why?
| | Genetic Loci | 1 | 2015 | 261 | 0.100 |
Why?
| | Risk Factors | 3 | 2018 | 10792 | 0.100 |
Why?
| | beta Catenin | 1 | 2015 | 253 | 0.100 |
Why?
| | Fibroblasts | 1 | 2019 | 1034 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2015 | 261 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 685 | 0.100 |
Why?
| | South Africa | 1 | 2014 | 261 | 0.100 |
Why?
| | Atrophy | 1 | 2013 | 201 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2013 | 307 | 0.100 |
Why?
| | Longitudinal Studies | 2 | 2017 | 2947 | 0.090 |
Why?
| | Cell Differentiation | 2 | 2017 | 2050 | 0.090 |
Why?
| | Renin | 1 | 2012 | 34 | 0.090 |
Why?
| | HLA-DR4 Antigen | 1 | 2012 | 74 | 0.090 |
Why?
| | Child, Preschool | 2 | 2020 | 11799 | 0.090 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2012 | 147 | 0.090 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 263 | 0.090 |
Why?
| | Hypoxia | 1 | 2018 | 1199 | 0.080 |
Why?
| | Major Histocompatibility Complex | 1 | 2011 | 229 | 0.080 |
Why?
| | Dosage Compensation, Genetic | 1 | 2010 | 11 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1786 | 0.080 |
Why?
| | HLA-DQ Antigens | 1 | 2011 | 173 | 0.080 |
Why?
| | Brain | 2 | 2020 | 2941 | 0.080 |
Why?
| | Microarray Analysis | 1 | 2010 | 117 | 0.080 |
Why?
| | HLA-DR Antigens | 1 | 2011 | 220 | 0.080 |
Why?
| | Hydrocortisone | 1 | 2012 | 304 | 0.080 |
Why?
| | Insulin Resistance | 1 | 2018 | 1241 | 0.080 |
Why?
| | Child | 4 | 2021 | 22657 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2430 | 0.080 |
Why?
| | Linkage Disequilibrium | 1 | 2010 | 247 | 0.080 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 323 | 0.070 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 409 | 0.070 |
Why?
| | Pedigree | 1 | 2010 | 514 | 0.070 |
Why?
| | Gene Frequency | 1 | 2010 | 481 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 612 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2609 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 771 | 0.070 |
Why?
| | Risk | 1 | 2010 | 911 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2020 | 11695 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 281 | 0.060 |
Why?
| | Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2026 | 4 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 2118 | 0.060 |
Why?
| | Adolescent | 3 | 2015 | 22453 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2925 | 0.060 |
Why?
| | Time Factors | 2 | 2016 | 7183 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.050 |
Why?
| | Protein Interaction Maps | 1 | 2024 | 51 | 0.050 |
Why?
| | Serine | 1 | 2024 | 145 | 0.050 |
Why?
| | Zinc Fingers | 1 | 2023 | 53 | 0.050 |
Why?
| | Introns | 1 | 2024 | 254 | 0.050 |
Why?
| | Prognosis | 1 | 2012 | 4293 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 392 | 0.050 |
Why?
| | Young Adult | 3 | 2018 | 14126 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5417 | 0.050 |
Why?
| | Glomerular Filtration Rate | 1 | 2026 | 760 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2020 | 17101 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 652 | 0.040 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 38 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5872 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 210 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 170 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 214 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1733 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 178 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 357 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 105 | 0.040 |
Why?
| | Hindlimb | 1 | 2019 | 131 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 59 | 0.040 |
Why?
| | Macaca | 1 | 2018 | 65 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 171 | 0.040 |
Why?
| | Oocytes | 1 | 2019 | 178 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 2019 | 121 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2018 | 83 | 0.030 |
Why?
| | Critical Illness | 1 | 2024 | 892 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 86 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 561 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2019 | 244 | 0.030 |
Why?
| | Guatemala | 1 | 2018 | 345 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 154 | 0.030 |
Why?
| | Adiponectin | 1 | 2018 | 244 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3550 | 0.030 |
Why?
| | United States | 1 | 2014 | 15988 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Fundus Oculi | 1 | 2016 | 89 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 56 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 28 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 521 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 627 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 109 | 0.030 |
Why?
| | Fatty Acids, Volatile | 1 | 2016 | 60 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2019 | 750 | 0.030 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2015 | 18 | 0.030 |
Why?
| | Iodide Peroxidase | 1 | 2015 | 34 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 72 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 308 | 0.030 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 48 | 0.030 |
Why?
| | Iron-Binding Proteins | 1 | 2015 | 43 | 0.030 |
Why?
| | Middle Aged | 2 | 2015 | 35928 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2015 | 91 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1742 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 145 | 0.030 |
Why?
| | Cohort Studies | 2 | 2016 | 5965 | 0.030 |
Why?
| | CTLA-4 Antigen | 1 | 2015 | 104 | 0.030 |
Why?
| | Muscle Development | 1 | 2015 | 116 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 780 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 975 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 833 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 854 | 0.030 |
Why?
| | Software | 1 | 2019 | 692 | 0.030 |
Why?
| | Feces | 1 | 2016 | 513 | 0.020 |
Why?
| | Autoantigens | 1 | 2015 | 429 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1540 | 0.020 |
Why?
| | Breast Feeding | 1 | 2016 | 448 | 0.020 |
Why?
| | Body Composition | 1 | 2016 | 706 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4155 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5233 | 0.020 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|